Rhythm Biosciences Ltd. announced the expansion of its executive management team by appointing experienced commercial professionals, Ms. Elena Deak and Mr. Paul Smith to the team. Ms. Elena Deak ­ Chief Commercial Officer: After returning to Australia in 2020, following several years managing European sales and marketing teams, Ms. Deak was most recently the Senior Product Manager & Nephrology Lead for CSL Vifor Pharma Australia. Possessing over 20 years executive leadership and technical experience within the pharmaceutical and biotechnology industries, Ms. Deak's previous experience includes the marketing and product launch of a colorectal cancer diagnostic test overseas.

With a Bachelor of Science degree with Honours, Ms. Deak brings a wealth of international and domestic experience and strong business acumen in delivering business opportunities across oncology and haematology, as well as dermatology, immunology, rheumatology and cardiology and will play the key role in commercialising ColoSTAT®. Mr. Paul Smith ­ Joint Company Secretary: Mr. Smith was recently the Chief Financial Officer for OPED Australia and comes to the team with more than 25 years of Australian and international experience of delivering financial and operational transformations for both private and public companies. With experience in the Australian, Chinese and US markets, Paul has led various financial, manufacturing, and operational projects to improve financial positions through systems, processes and procedures.

Mr. Smith has a Bachelor of Business and post grad in Accounting from Monash University. His experience in the healthcare industry, including in manufacturing and commercialisation will be an important asset to the business. Ms. Deak and Mr. Smith are both excited by the opportunity to join Rhythm Biosciences and look forward to working with the operational teams in developing and executing the financial and commercial strategies to successfully progress the Company into the future.